Please provide your email address to receive an email when new articles are posted on . Intravitreal steroids have been widely used in the treatment of various ocular pathologies including macular ...

A sustained-release dexamethasone device implanted during pars plana vitrectomy may be effective in pre-emptively reducing macular edema in patients with various underlying ocular diseases at risk for ...

The US Food and Drug Administration has approved Allergan's Ozurdex (dexamethasone intravitreal implant) 0.7 mg for use in adult patients with diabetic macular edema who have had an artificial lens ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE: AGN) announced today that the U.S. Food and Drug Administration (FDA) has approved OZURDEX® (dexamethasone intravitreal implant) 0.7 mg, a ...

To evaluate the morphological and functional changes following intravitreal Ozurdex (dexamethasone implant) injections in patients with macular oedema (MO) secondary to retinal vascular diseases. The ...

It is with great interest that we read another case of Ozurdex implant malpositioned in the crystalline lens, as reported by Chalioulias and Muqit. 1 Although the complication is rare, with increasing ...

Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has issued final guidance recommending OZURDEX® (dexamethasone 0.7mg intravitreal implant in applicator) ...

OZURDEX (dexamethasone) intravitreal implant Allergan announced that the Food and Drug Administration (FDA) has approved Ozurdex (dexamethasone intravitreal implant) for the treatment of diabetic ...

Allergan’s eye drug Ozurdex has been approved in the EU to treat a sight-threatening condition that affects people with diabetes. The European Commission granted marketing authorisation to Ozurdex, an ...

Allergan has completed the topline analysis of data from the Company's Stage 3, Phase 2 study of abicipar pegol (Anti-VEGF DARPin ®) in neovascular, or "wet," age-related macular degeneration (AMD).

The Indian rupee is expected to face continued pressure in the coming week, and traders will take cues from how forcefully the Reserve Bank of India defends the currency near its all-time low.